The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
January 15th 2025
Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) or retinal vein occlusion (RVO).
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
2.0 Credits / Ophthalmology/Optometry
View More
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
1.5 Credits / Ophthalmology, Optometry
View More
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adhere...
1.5 Credits / Ophthalmology/Optometry
View More
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
1.5 Credits / Oncology
View More
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes
1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
View More
Faricimab: Mechanism of Action, Payers’ Perspective, and Real-World Experience
February 23rd 2023Key opinion leaders discuss faricimab, its impact on the treatment landscape for wet AMD/DME, and what payers should look for when considering formulary positioning or utilization-management strategies.
Watch
Variability of Frequency Dosing for Anti-VEGF Agents in the Treatment of Wet AMD
February 23rd 2023Dr Coney discusses the variability of frequency dosing with anti-VEGF therapy in patients with wet AMD and DME, and Dr Sheth expands on Ang-2 and its contribution to the development of vascular instability in wet AMD.
Watch
Anti-VEGF and Gene Therapy Impacting Wet AMD and DME Treatment Landscapes
February 16th 2023Dr Sheth discusses his insights on anti-VEGF therapy that he has noticed in the treatment of wet AMD over the last decade, and Caesar Luo, MD, FASRS, FACS shares his insight on new treatment options and their impact on patient access and cost considerations.
Watch
Dr Michael Cohen Discusses Accessibility of Future Gene Therapies
February 9th 2023Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.
Watch
Dr Michael Chiang Speaks About the NEI's Involvement in AMD, Addressing Health Disparities
January 26th 2023Michael Chiang, MD, director of the National Eye Institute, spoke about efforts to address age-related macular degeneration (AMD) as well as health disparities in clinical trials and access to treatment.
Watch
Gene Variants That Protect Against Alzheimer Disease Could Increase Risk of AMD
December 1st 2022The risk of age-related macular degeneration (AMD) could be linked to structural variations in the APOE gene that were previously found to be associated with protection against Alzheimer disease.
Read More
A report from the World Health Organization highlights the global burden of oral diseases; study shows the predictive value of a “good” cholesterol level varies between Black and White patients; CDC report suggests people with impaired vision are not receiving proper health care.
Read More